Heidi Hingtgen Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: S77w12929 Mcshane Dr, Muskego, WI 53150 Phone: 414-529-0100 |
Marie Hallett Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: W140s7390 Settler Way, Muskego, WI 53150 Phone: 414-881-3496 |
Sandra Ann Ceranski, O.T.R. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: W131s6680 Kipling Dr, Muskego, WI 53150 Phone: 414-425-0090 |
Lauren Wood Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: S74w16775 Janesville Rd, Muskego, WI 53150 Phone: 414-422-2191 |
Ms. Judy Ann Shea, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: S77w12929 Mcshane Dr, Muskego, WI 53150 Phone: 414-529-0100 |
Mrs. Brisha Ann Riggs, COTA/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: S77w12929 Mcshane Dr, Muskego, WI 53150 Phone: 414-525-6517 Fax: 414-427-4828 |
News Archive
Medivir and Meda today announced an agreement for the commercialization of Medivir's cold sore product which will be marketed in North America under the trade name Xerese™.
Biologics, Inc., an integrated oncology management company, is pleased to announce it has been selected by AstraZeneca as the exclusive U.S. strategic channel partner for vandetanib.
IRIN examines how a recent resolution to create an agency to promote women's "rights and wellbeing" by the U.N. General Assembly is being welcomed by international HIV/AIDS advocates. According to IRIN, "[w]omen make up 60 percent of people living with AIDS in sub-Saharan Africa, a figure that rises to 75 percent in the 15-24 age range. In Asia, nearly 50 million women are at risk of becoming infected with HIV from their partners."
Drinking a glass of red wine a day may cut a man's risk of prostate cancer in half, and the protective effect appears to be strongest against the most aggressive forms of the disease
The prevalence of abnormal ankle-brachial index (ABI) test results among individuals tested for peripheral arterial disease (PAD)—and who are not considered at high risk of a coronary heart event by Framingham-based risk factors—is high and provides another way to identify those who may be at risk for future heart attacks, say researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.
› Verified 1 days ago